.svg)
Human-Relevant Discovery Begins With the Model: A Conversation With Shushant Jain
.png)
Building Human-Relevant Immuno Oncology Models: A Conversation With Ncardia’s Sanne Holt
Driving Predictive Science Forward: Inside the Shift Toward Human-Relevant Drug Discovery
The FDA Is Moving Past Animal Testing. Here’s How Ncardia Helps Make It Happen
Press release: Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study
Ncardia Acquires STAR-CRISPR Technology for Advanced Gene Editing of iPSCs
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
